Delivery Order SPE2DB22D3301-SPE2DB25FY4QU
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,598.50, is for the delivery of Renflexis 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $24,418.02 to supply Renflexis 100 mg vials. The contract has an ultimate completion date of September 27, 2024 and is a firm fixed price contract. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to the U.S. federal government, including military treatment facilities and veterans' healthcare programs. This award...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,093.08, is for the delivery of Renflexis 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $10,907.52, is for the supply of the pharmaceutical product Renflexis 100 mg vials. The ultimate completion date is July 22, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,608.36 firm fixed-price delivery order is for the supply of Renflexis 100 mg vials, a specialty medication. The contract has a period of performance running through January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,516.88, is for the delivery of Renflexis 100 mg vials, a specialty medication. The contract is a delivery order with a firm fixed price pricing type and has a completion date of August 24, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
This is a $18,510.08 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the pharmaceutical product Renflexis 100 mg vials. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded multiple federal contracts to supply a variety of prescription medications, medical supplies, and equipment to support military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Renflexis 100 mg vials. The contract has a ceiling value of $27,832.00 and a completion date of February 10, 2025. It is a firm-fixed-price contract type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
This federal contract award is for the delivery of Renflexis 100 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,723.11, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 24, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Renflexis. The $5,386.56 firm fixed-price contract has an ultimate completion date of August 28, 2023. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...